Glaxo Smith Kline Africa Open Lab Research Awards for African Scientists

GSK’s Africa NCD Open Lab was established in 2014 as part of a series of GSK strategic investments to provide long term support for scientific research in the field of non-communicable diseases (NCDs) in sub Saharan Africa. The goal is to work in partnership with funders, researchers and academic groups to share expertise and resources to conduct research in Africa aimed at increasing scientific understanding of the unique attributes of NCDs.In November 2014 the Open Lab launched its first call for proposals in eight African countries, with a total of £4 million made available to fund
Glaxo Smith Kline Africa Open Lab Research Awards for African Scientists